Table 3 Univariate analysis of the influencing factors of gout recurrence
Category | Gout recurrence | P | |
|---|---|---|---|
Yes | No | ||
Age, means ± SD, year | 56.2 ± 15.54 | 52.61 ± 14.11 | 0.365 |
Gender, n (%) | 0.252 | ||
 Male | 19 (34.5) | 36 (65.5) |  |
 Female | 1 (11.1) | 8 (88.9) |  |
BMI, means ± SD, Kg/m2 | 25.68 ± 3.88 | 23.73 ± 2.94 | 0.031 |
BMI group, n (%) | 0.090 | ||
 No obesity (BMI < 28 kg/m2) | 15 (27.3) | 40 (72.7) |  |
 Obesity (BMI ≥ 28 kg/m2) | 5 (55.6) | 4 (44.4) |  |
Gout attack uric acid, means ± SD, μmol/L | 409.26 ± 137.95 | 333.08 ± 146.48 | 0.054 |
Gout relieves uric acid, means ± SD, μmol/L | 394.79 ± 100.86 | 346.22 ± 93.89 | 0.066 |
Uric acid drop ratio, means ± SD | 0.22 ± 0.11 | 0.34 ± 0.19 | 0.011 |
Inflammatory markers during gout attack, means ± SD: | |||
 WBC (109/L) | 11.56 ± 2.61 | 10.77 ± 3.69 | 0.396 |
 CRP (mg/dl) | 118.37 ± 58.04 | 117.99 ± 77.76 | 0.985 |
 ESR (mm/h) | 74.45 ± 41.33 | 66.99 ± 31.52 | 0.430 |
Inflammatory markers in gout remission, means ± SD | |||
 WBC (109/L) | 8.75 ± 2.64 | 8.47 ± 2.66 | 0.701 |
 CRP (mg/dl) | 52.42 ± 34.08 | 47.52 ± 48.54 | 0.685 |
 ESR (mm/h) | 55.6 ± 19.84 | 51.97 ± 23.76 | 0.554 |
Fever, n (%) | 8 (40.0) | 14 (31.8) | 0.523 |
Hypertension, n (%) | 9 (45.0) | 21 (47.7) | 0.839 |
Hyperuricemic, n (%) | 17 (85.0) | 21 (47.7) | 0.005 |
Hyperlipidemia, n (%) | 16 (80.0) | 23 (52.3) | 0.035 |
Diabetes, n (%) | 7 (35.0) | 11 (25.0) | 0.410 |
Coronary heart disease, n (%) | 7 (35.0) | 15 (34.1) | 0.943 |
Renal insufficiency, n (%) | 5 (25.0) | 3 (6.8) | 0.041 |
Smoking, n (%) | 10 (50.0) | 13 (29.5) | 0.114 |
Tophi, n (%) | 14 (70.0) | 8 (18.2) | < 0.001 |
Diuretics, n (%) | 10 (50.0) | 13 (29.5) | 0.114 |
Drinking, n (%) | 5 (25.0) | 14 (31.8) | 0.580 |
Aspirin, n (%) | 5 (25.0) | 9 (20.5) | 0.683 |
Affected joints, n (%) | 0.884 | ||
 Single joint | 14 (70.0) | 30 (68.2) |  |
 Multi-joint | 6 (30.0) | 14 (31.8) |  |